Systemic lupus erythematosus and ""lupus dyslipoproteinemia""

dc.creatorCARVALHO, Jozelio Freire de
dc.creatorBONFA, Eloisa
dc.creatorBORBA, Eduardo Ferreira
dc.date.accessioned2012-10-19T17:08:40Z
dc.date.accessioned2018-07-04T15:05:23Z
dc.date.available2012-10-19T17:08:40Z
dc.date.available2018-07-04T15:05:23Z
dc.date.created2012-10-19T17:08:40Z
dc.date.issued2008
dc.identifierAUTOIMMUNITY REVIEWS, v.7, n.3, p.246-250, 2008
dc.identifier1568-9972
dc.identifierhttp://producao.usp.br/handle/BDPI/21656
dc.identifier10.1016/j.autrev.2007.11.016
dc.identifierhttp://dx.doi.org/10.1016/j.autrev.2007.11.016
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1618430
dc.description.abstractA growing body of evidences reinforces the close link between systemic lupus erythematosus (SLE) and atherosclerosis which is due to traditional and nontraditional risk factors for cardiovascular diseases. It is now recognized that SLE has a particular pattern of dyslipoproteinemia characterized by low HDL levels and increased triglycerides, which is aggravated by flares. Multiple mechanisms can induce an altered lipoprotein metabolism in SLE such as cytokines produced during systemic inflammation, autoantibodies and therapy. (C) 2007 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCIENCE BV
dc.relationAutoimmunity Reviews
dc.rightsCopyright ELSEVIER SCIENCE BV
dc.rightsrestrictedAccess
dc.subjectsystemic lupus erythematosus
dc.subjectlipoprotein
dc.subjectdyslipoproteinemia
dc.subjectatherosclerosis
dc.subjectdyslipidemia
dc.subjectatherosclerosis
dc.titleSystemic lupus erythematosus and ""lupus dyslipoproteinemia""
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución